Background: The CXC chemokine receptor 4 (CXCR4) and its ligand, stromal cell–derived
factor‐1 (SDF‐1α or CXC chemokine ligand 12) are involved in the trafficking of leukocytes …

Purpose: Approximately 200,000 women are diagnosed with breast cancer in the US every
year. These patients commonly suffer from oral complications of their cancer therapy. The …

Human very small embryonic-like (hVSEL) cells are a resident population of multipotent stem
cells in the bone marrow involved in the turnover and regeneration of tissues. The levels of …

Background: Historic evidence suggests that use of high‐dose combined oral contraceptives
(OCs) (containing >50 µg of estrogen and ≥1 mg progestin) places women at increased …

Background: Aromatase inhibitor (AI) use results in low estrogen levels, which in turn affect
bone mineral density (BMD). Periodontitis, alveolar bone loss, and tooth loss are associated …

Aim The objectives are to compare responses of breast cancer (BCa) treatment groups (chemotherapy,
tamoxifen, and aromatase inhibitors (AIs) to each other and a control regarding (a…

Aim This study was conducted to determine periodontal changes in postmenopausal breast
cancer ( BC a) survivors using aromatase inhibitors ( AI ) as compared to postmenopausal …

Current adjuvant treatment modalities for breast cancer that express the estrogen receptor
or progesterone receptor include adjuvant anti-estrogen therapies, and tamoxifen and …

Introduction Aromatase inhibitors (AIs) are a well-established component of adjuvant therapy
in postmenopausal women with hormone receptor (HR) + early stage breast cancer (BCa). …

Purpose: This study aimed to: (1) compare caregivers' perceptions of their children's oral
health status with clinical findings; and (2) investigate the influence of caregivers' attitudes, …